Sunday, September 06, 2020

Evolution of the COVID-19 vaccine development landscape

Amazing stuff! For a virus that was essentially unknown before December 2019, we now have 321 vaccine candidates and 32 of them in clinical trials as of 9/2/2020. This is absolutely mind blowing/breath taking and most likely unprecedented!

Now it is high time to finally defeat the influenza virus!

Evolution of the COVID-19 vaccine development landscape The COVID-19 vaccine R&D landscape has developed at unprecedented scale and speed since our initial analysis in April identified 115 candidates in the pipeline (Nat. Rev. Drug Discov. 19, 305–306; 2020). In this updated overview, we focus on candidates in clinical trials and provide some initial perspectives on their clinical development.

No comments: